Cargando…
Bioengineered Nisin A Derivatives Display Enhanced Activity against Clinical Neonatal Pathogens
Neonatal infection is a significant cause of mortality and morbidity in infants. The global incidence of multi-drug resistance continues to rise among neonatal pathogens, indicating a need for alternative treatment strategies. Nisin is an antimicrobial peptide that exhibits broad-spectrum activity a...
Autores principales: | Desmond, Anna, O’Halloran, Fiona, Cotter, Lesley, Hill, Colin, Field, Des |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9686653/ https://www.ncbi.nlm.nih.gov/pubmed/36358171 http://dx.doi.org/10.3390/antibiotics11111516 |
Ejemplares similares
-
Bioengineered nisin derivatives with enhanced activity in complex matrices
por: Rouse, Susan, et al.
Publicado: (2012) -
Bioengineered Nisin A Derivatives with Enhanced Activity against Both Gram Positive and Gram Negative Pathogens
por: Field, Des, et al.
Publicado: (2012) -
A Bioengineered Nisin Derivative to Control Biofilms of Staphylococcus pseudintermedius
por: Field, Des, et al.
Publicado: (2015) -
Bioengineered Nisin Derivative M17Q Has Enhanced Activity against Staphylococcus epidermidis
por: Twomey, Ellen, et al.
Publicado: (2020) -
Studies with bioengineered Nisin peptides highlight the broad‐spectrum potency of Nisin V
por: Field, Des, et al.
Publicado: (2010)